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Within recent years hydrazine and the methyl substituted hydrazines have come 
into considerable use as rocket fuels. As a result of this increased production 
of hydrazines, the possibility of accidental human exposure is of considerable 
interest. Obvious concern results from the fact that hydrazine had been used 
as an experimental means of producing fatty liver in experimental animals for 
many years. On an acute toxicity basis, O’Brien and coworkers (1964) reported 
comparative lethal dosebo ( LDSo) values for hydrazine 64 mg/ kg ( 2  mmoles/kg) , 
rnonomethylhydrazine (MMH) 28 mg/kg (0.61 mmoles/ kg), 1,l-dimethyl- 
hydrazine (unsymmetrical dimethylhydrazine, UDMH) 102 mg/kg ( 1.7 m- 
moles/ kg) , and 1 ,Zdimethylhydrazine (symmetrical dimethylhydrazine, SDMH) 
essentially nontoxic even at dosages of 500 mg/kg. The structures of these four 
compounds are shown in FIGURE 1, and it appears that a free amino group is 
essential for biological activity in this group of compounds. Barth and associates 
( 1967) have previously reported the diuretic effect induced by UDMH, and it is 
interesting to note that of the four hydrazines shown in FIGURE 1, only SDMH 
is without diuretic effect, again emphasizing the biological activity of the free 
amino groups in this series of compounds. Killam and Bain reported in 1957 
that thiosemicarbazide, furoyl hydrazide, and isonicotinic acid hydrazide would 
inhibit, in vitro, enzyme systems catalyzed by vitamin Bg. Thus it was suggested 
that the epileptiform convulsions produced by these compounds could be due 
to an inhibition of one or more of the enzyme systems requiring pyridoxal phos- 
phate as a cofactor. In related findings, Reeves (1961 ) and Back and colleagues 
(1963) reported the use of pyridoxine and pyridoxamine as effective antidotes 
for UDMH and MMH toxicity. Similar findings on the effectiveness of pyridoxine 
in alleviating the convulsive symptoms of hydrazine toxicity have not been 
consistent. Medina ( 1963) reported that convulsions induced by hydrazine could 
be blocked by pyridoxine, but not by pyridoxal. 
O’Brien and associates (1964) reported that although hydrazine can be a con- 
vulsant at high doses, at doses near the LDJO it is not primarily a convulsant but 
is a depressant. On this basis, they suggest that hydrazine probably has a mode of 
action different from UDMH and MMH. It is interesting to note that this sug- 
gestion correlates with the early reports that brain levels of y-amino-butyric acid 
(GABA) are depressed after UDMH treatment but apparently elevated after 
hydrazine treatment. 
Reversal of Hydrazine Toxicity b y  Vi tamin BB 
A number of studies from this laboratory have investigated the relationship of 
the various hydrazines to the Be vitamers both in v ivo  and in vitro.  
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FIGURE 1. Structure of hydrazine and methyl substituted hydrazines. 
Due to the time lag between administration of the hydrazines and the appear- 
ance of convulsions, it appeared possible that the formation of metabolites might 
be responsible for convulsive activity of these compounds. The direct injection 
of 3.5 to 4.0 mg of UDMH intracerebrally brought about severe convulsive 
seizures in rats similar to those seen following intraperitoneal injections of 
UDMH. Considerably higher quantities, however, must be injected intraperitone- 
ally (40 to 50 mglkg) before consistent convulsive seizures appear in rats. Thus it 
appears that the convulsive seizures are mediated centrally. In a related series of 
, 
TABLE 1
EFFECT OF INTRACEREBRAL INJECTION OF PYRIDOXINE (PY), PYRIDOXAL (PAL), 
AND PYRIDOXAL PHOSPHATE (PALP) ON NORMAL AND UDMH-TREATED. RATS 
PY PAL PALP 
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UDMH (120 mg/kg, I.P.) 90 min/before B. administration. 
t Convulsions: number convulsing/number treated. 
$ Mortality: number dead/number treated. 
(Reprinted with permission of author and Pergamon Press from Biochemical Pharmacology 
15: 1614-1618 - Geakc, Barth & Cornish, 1966.) 
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studies, it has been shown that intracerebral injections of the various Be vitamers 
are effective antidotes to intraperitoneal injections of UDMH (TABLE 1).  This 
dose of UDMH, (120 mg/kg I.P.) produces convulsions in all animals and has a 
mortality rate of 94%. Intracerebral injections of 3 to 6 mg of pyridoxine (PY), 4 
mg of pyridoxal (PAL), or 1 mg of pyridoxal phosphate (PALP) without hydra- 
zine produced convulsions and death in nearly all rats. In animals receiving 120 
mg/kg of UDMH I.P. and 3 to 4 mg of PY intracerebrally (I.C.), 11 of 14 animals 
survived; thus the two compounds were mutually protective. At lower doses of PY 
ranging from 0.05 to 3 mg, nearly all rats survived the normally lethal effect of 
this dose of UDMH. PAL was also an effective antidote to UDMH over a some- 
what similar dosage range. PALP, however, was effective only within a rela- 
tively limited range of values. A related study of the effect of intraperitoneal 
injections of the Be vitamers on UDMH toxicity is shown in TABLE 2. Ten mg or 
more of PY was effective in preventing both convulsive seizures and mortality 
in rats receiving 120 mg/kg of UDMH I.P. PAL was effective over the rela- 
tively narrow range of 5 to 10 mg/kg. Dosages of PAL either above or below 
these amounts were only partially effective or ineffective. In a similar way, intra- 
TABLE 2
EFFECT OF INTRAPERITONEAL INJECTION OF PYRIDOXAL (PAL), PYRIDOXAL PHOSPHATE (PALP), 
OR PYRIDOXINE (PY), ON NORMAL AND UDMH-TREATED RATS. 
Be Vitamer Dose 























30 X 2 t  
5 x 2 t  





UDMH only 90/90 
UDMH (120 mg/kg, I.P.) 90 minutes before Be administration. 
t First dose of PALP given 90 minutes after UDMH; second dose 45 minutes later. 
(Reprinted with permission of author and Pergamon Press from Biochemica/ Pharmacology 
15: 1614-1618 - Geake, Barth &Cornish, 1966.) 
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EFFECT OF Be VITAMERS ON HYDRAZINE-TREATED. RATS 
Mortality 
94, 
Pyridoxine 20 I.P. 5/6 6/6 6/6 0 
100 S.C. 4/6 4/6 4/6 33 
0.5 mg/rat I.C. 0/4 0/4 0/4 100 
1.0 mg/rat I.C. 0/4 0/4 0/4 100 
Vitamer Dose (mg/kg) Be Route 1 hr 6hr  24hr Survived 
15 I.P. 2/6 2/6 67 
15 I.V. :$8 0/18 3/18 83 
Pyridoxal 10 I.P. 5/6 6/6 6/6 0 
10 I.V. 1/6 1/6 2/6 67 
Pvridoxal 
phosphate 5 LP. 3/6 5/6 5/6 17 
5 I.V. 3/6 3/6 5/6 17 
Hydrazine 100 mg/kg - 21/41 37/41 41/41 0 
All rats received 100 mg/kg of hydrazine, I.P. 
peritoneally administered PALP prevented all deaths only when administered 
at one dose level (10 mg/kg). No dosage of PALP was completely effective in 
preventing convulsions. 
Since studies have revealed that PY, PAL, and PALP are all successful anti- 
dotes for UDMH, these Be vitamers were studied for their effectiveness in hydra- 
zine toxicity. The doses, routes of injection, and results are given in TABLE 3. 
PY proved to be the most effective Be vitamer for therapy of hydrazine toxicity. 
PY was most successful at a dose of 15 mglkg given I.V. or at a dose of 0.5 or 
1.0 mg/rat given I.C. By both routes, PY was given 15 to 20 minutes after 
hydrazine. Five rats which are not recorded in the Table were given 15 mg of 
PY/kg I.V. immediately prior to impending death from 100 mg of hydrazine/kg. 
These rats survived, indicating that PY is a quite good antidote for hydrazine 
toxicity, even when injected rather late, Intravenous PAL at 10 mg/kg protected 
four of six rats, but PALP was ineffective, with only one of six rats surviving. 
Surviving rats always appeared lethargic the day after the experiment but were 
quite normal on the third day. Eleven of 18 rats receiving 400 to 500 mglkg of 
PY orally also survived a dose of 100 mg/kg of hydrazine. In this case, PY was 
given 30 minutes before the hydrazine injection. 
Two hydrazine-treated rats that received 0.5 mg PY (I.C.) had moderate to 
severe hyaline droplet change in the renal tubular epithelium and in the hepatic 
cord cells. The cord cells also showed small necrotic foci with neutrophil accumu- 
lation. There was severe periportal lipid infiltration. Two rats that received 1 mg 
PY I.C. were sacrificed 48 hours after the hydrazine injection. These rats had 
renal tubular necrosis, and there were numerous areas of necrosis in the liver as 
well as severe periportal lipid infiltration. Intracerebral Be apparently prevents 
convulsions by action within the brain, but perhaps because of the small quanti- 
ties used, the severe histopathologic effects of hydrazine on other organs was 
not diminished. 
Tryptophan Metabolism 
Since vitamin Be is involved in tryptophan metabolism, it was of interest to 
determine whether UDMH would alter the amounts of xanthurenic acid or kynu- 
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renic acid excreted in the urine. Such a finding would also be of value in assessing 
human exposures to UDMH. Six-hour post-UDMH urine samples were collected 
under toluene from rats kept in individual metabolic cages. Six or more animals 
were included in each group. Fluorometric determination of xanthurenic and 
kynurenic acids was carried out by the method described by Satoh and Price 
(1958). Normal animals excreted an average of 3.5 X mg of kynurenic 
acid and 5.0 X mg of xanthurenic acid over the six-hour period. The values 
obtained for UDMH-treated rats (80 mg/kg I.P.) were 2.8 X mg and 
5.2 X lop4 mg respectively, not significantly different from the control animals. 
Unfortunately, short-term changes during the six-hour period would not have 
been detected by this procedure. 
Electrolyte Distribution 
Studies on electrolyte distribution in the urine of rats treated with UDMH have 
been previously reported (Barth et al., 1967). The effect of UDMH on brain 
electrolytes has also been investigated. Homogenates of whole brain were made 
in distilled deionized water and the electrolyte concentration measured with a 
Beckman flame photometer. The results are shown in TABLE 4. Total electrolyte 
levels of Na, K, and Ca in treated animals were not significantly different from 
the controls. The values were rather consistent except for one group of UDMH 
rats where the mean calcium level appears depressed. Due to considerable animal 
variation within groups, this is not a statistically significant difference. Mito- 
chondrial preparations from brains of normal rats and rats given 100 mg/kg of 
UDMH were also analyzed for potassium and calcium levels. Animals were 
sacrificed two hours after treatment and mitochondria prepared according to 
the method of Lovtrup and Zelander (1962). The results of these measurements 
are shown in TABLE 5. No differences were noted in mitochondria1 Ca or K 
levels in these two groups of rats. It is realized that these are rather gross 
measurements in that the whole brain was utilized, thus electrolyte changes 
within a small localized area would perhaps go undetected. 
TABLE 4 
FROM NORMAL AND UDMH-TREATED RATS 
ELECTROLYTE LEVELS IN WHOLE BRAIN HOMOGENATES 
UDMH Sacrifice No. of mEq/kg Tissue. 
mg/ks Time (hr) Rats Na K Ca 
Controls - 12 49.4 f 0.4 90+- 1 3.0 f 0.7 
SO 2 13 50.9 2 0.6 88 f 1 1.7 f 0.2 
100 2 12 50.5 f 0.5 91 f 1 3.1 f 0.4 
Average f SE. 
TABLE 5 
ELECTROLYTE LEVELS IN BRAIN MITOCHONDRIAL PREPARATIONS FROM NORMAL AND 
UDMH (100 mg/kg)-TREATED RATS 
Sacriflce No. of K Ca 
Time (ht) Rat8 u / m s  N* fis/mg N* 
Normal - 10 161 +- 11 72 f 13 
UDMH-Treated 2 10 161 f 4 74f 17 
Average f SE. 
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Amino Acid Metabolism 
As early as 1926. Lewis and Izume suggested a hydrazine block of amino acid 
utilization. Subsequent findings with in vitro systems (Amenta & Johnston, 
1963; Killam & Bain, 1957, McCormick & Snell, 1961) have demonstrated that 
hydrazine and some of its derivatives do produce a block in amino acid metabol- 
ism which can be reversed by pyridoxal phosphate. Simonsen and Roberts, 
( 1967) have shown increased levels of certain amino acids in tissues of hydrazine- 
treated rats. However, whether amino acid imbalance bears any causal relation- 
ship to the convulsive seizures in hydrazine-treated rats is not clear. A recent 
paper from our laboratory reported plasma and tissue amino acid levels, as well 
as the effect of amino acid loading on hydrazine treated rats. FIGURE 2 illustrates 
the effect of tyrosine loading on brain and plasma tyrosine levels in control and 
hydrazine-treated rats. Plasma tyrosine levels in tyrosine-loaded rats are two 
to three times greater than control levels one to two hours after dosing. Brain 
levels show a continuous rise, and at three hours they are approximately four 
times control levels. Plasma and brain levels show tremendous increases in tyro- 
sine levels when tyrosine-loaded rats are given hydrazine. Plasma levels are 
approximately 15 times control values, while brain tryosine levels rapidly in- 
crease five- or sixfold within three hours after treatment. When a non-tryosine- 
loaded group of animals were injected with hydrazine, it was found that plasma 
levels at three hours were five times those of the control group receiving only 
the tyrosine load. At the same time, brain tyrosine levels in hydrazine-treated 
rats were quite comparable with those of rats that were tyrosine-loaded. The 
elevated tyrosine levels in plasma and brain of tyrosine-loaded hydrazine-treated 
rats demonstrates either a remarkable increase in the rate of absorption or a 
severe inhibition of metabolism or excretion of tyrosine. Several earlier studies 
when both hydrazine and tyrosine were given intraperitoneally showed similar 
results. To obviate peritoneal irritation, and perhaps a direct effect on the rate of 
tyrosine absorption, hydrazine was given subcutaneously and tyrosine intra- 
peritoneally in the present studies. Under similar experimental conditions, total 
plasma amino acids were measured (FIGURE 3) .  Tyrosine loading was not a 
factor in these studies, since it did not materially influence total a-amino nitrogen 
levels of the control group. The three hydrazine treated groups showed a con- 
tinuous rise in plasma a-amino nitrogen levels over the three-hour period follow- 
ing injection with 60 mg/kg hydrazine subcutaneously. Eighteen hours after 
hydrazine injection, plasma a-amino nitrogen levels were 15.2 & 1.7 mg/ 100 ml, 
liver 0.89 -t 0.02, and brain 0.62 & 0.01 mg/g, compared to control levels of 
6.6 * 0.43, 0.45 * 0.02, 0.57 & 0.01 respectively. Thus although plasma and 
liver levels were still elevated, brain levels were near normal at this time. Since 
these studies were carried out on 18-hour fasted rats, the amino acid elevations in 
plasma and tissue must arise from endogenous metabolism. These findings are 
consistent with the hypothesis that amino acid metabolism is inhibited in hy- 
drazine rats, apparently due to an acute vitamin B8 deficiency. Several pieces of 
information, however, suggest that factors other than PALP deficiency may play 
a role in the effect of hydrazine on amino acid levels. These will be considered in 
the general discussion. 
Chemical Reactivity 
In vivo studies of the reaction rates between the various hydrazines and PALP 
(Cornish & Ling) show that the reaction between hydrazine and PALP is 
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TYROSINE 8 SALINE 
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FIGURE 2. Tyrosine levels in plasma and brain. Rats were dosed as follows: tyrosine, 100 
mg/rat I.P.; hydrazine, 60 mg/kg S.C.; vitamin B, (pyridoxine HCI), 15 mg/kg I.P. (Copy- 
righted figure reproduced by permission of Toxicology and Applied Pharmacology (Cornish 
& Wilson, 1968).) 
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FIGURE 3. a-Amino nitrogen levels in plasma. Rats were dosed as follows: tyroshe, 100 
mg/rat I.P.; hydrazine, 60 mg/kg S.C.; vitamin B, (pyridoxine HCI), 15 mg/kg 1.P. (Copy- 
righted figure reproduced by permission of Toxicology and Applied Pharmacology (Cornish & 
Wilson, 1968).) 
without a free amine, does not react with PALP. This is consistent with in virro 
findings that with relatively high doses ( LDloo), animals dosed with hydrazine 
die within a few minutes, whereas animals receiving UDMH or MMH may 
survive for a considerable time. Hydrazine, being a reactive compound, may of 
course react with other biological components at an equally rapid rate. 
General Discussion 
The earliest reports of the ability of pyridoxine to reverse the toxic effects of 
UDMH made the simple hypothesis of an acute vitamin Ba deficiency most at- 
tractive. This was particularly true since it can be demonstrated, both in vifro and 
in vivo, that UDMH forms a hydrazone with PALP. Unfortunately the hy- 
drazones themselves appear to have considerable toxicity and may play a role in 
the in vivo response to various hydrazines. A recent report by Furst and Gustav- 
son (1967) compared the toxicity of UDMH, MMH, and the corresponding 
hydrazones of pyridoxal and pyridoxal-5-phosphate. In mice, the characteristic 
convulsive seizures were brought on by both the hydrazines and the hydrazones. 
In general, the hydrazones were more toxic than the hydrazines themselves. For 
example, at 100 mg/kg I.P., UDMH was not a convulsant in the mouse, while 
the corresponding hydrazones of PAL and PALP were convulsants at dosages of 
5 mg/ kg. One must keep in mind, however, that the intraperitoneal injection 
of a reactive hydrazine may not be comparable to the injection of a hydrazone 
in which the chemically reactive groups of both compounds have been combined. 
Thus, certainly absorption and distribution of these two materials will vary 
greatly. For comparison on a mechanistic basis, it would be necessary to know 
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the concentrations of each reaching the pharmacologically active site, presumably 
in the brain, Such findings, however, are consistent with the report of Uchida 
and O’Brien (1964), which showed that total PALP levels in the brain of rats 
was not reduced at the time of seizures when rats were given UDMH. However, 
intraperitoneal injections of PY increased brain levels of PALP in control and 
SDMH-treated rats somewhat more than in UDMH-treated animals. The authors 
conclude that the short-term effects of these hydrazines are not due to a re- 
duction of the prevailing levels of total brain PALP. Several alternative hy- 
hypotheses are suggested, including metabolic compartmentalization of PALP, 
or perhaps a direct action of the hydrazines on brain glutamic decarboxylase. 
The data shown in TABLES 1, 2 & 3, which indicate that all forms of the B6 
vitamer are at least partially effective against the convulsive effects of the 
hydrazines, clarifies to some extent the conflicting data on the ability of PY 
but not PAL or PALP to prevent convulsive seizures in UDMH-treated rats. 
It illustrates the relatively narrow range of effective dosages of PAL and PALP, 
amounts above or below these ranges not being effective. Thus, findings will 
vary, depending upon the dosage used. 
With respect to specific enzymatic activity that might be affected, early studies 
obviously concerned themselves with brain glutamic acid decarboxylase (GAD) 
and y-aminobutyric acid (GABA) levels. Medina reported (1963) rat brain 
glutamic acid decarboxylase activity severely inhibited by both hydrazine and 
UDMH. y-aminobutyric acid transaminase activity was markedly inhibited by 
hydrazine but only slightly affected by UDMH. GABA levels were elevated in 
hydrazine-treated rats and depressed in UDMH-treated animals. Pyridoxine, at 
the single dosage used, did not alter the activity of GAD or GABA-transaminase 
in hydrazine-treated animals, but did return GAD and GABA to essentially 
normal values in UDMH-treated animals. The authors conclude that a direct 
relationship between the metabolism of GABA and the convulsive action of 
hydrazines could not be shown. 
Any overall hypothesis of the mode of action of the convulsigenic hydrazines 
must take into account the initial problems of varying rates of absorption and 
distribution, passage through the blood-brain barrier, the formation of PAL or 
PALP hydrazones, which in themselves are convulsants, the inhibition of a 
number of B6-requiring enzymes by the hydrazines or their hydrazones, and the 
possible localized B6 deficiency within critical brain areas. Although PALP 
deficiency within the brain has not been demonstrated, the ability of appropriate 
small intracerebral and htraperitoneal doses of the B6 vitamers to completely or 
partially protect animals against the toxic effects of UDMH, MMH, and hy- 
drazine most simply implies a deficiency state at some critical metabolic point. 
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